Table 7 Factors associated with confirmed malaria fever incidence in the PACOME participants Multivariate Poisson regression*
Variable | Outcome | |||
|---|---|---|---|---|
Confirmed malaria (N = 410) | Confirmed or suspected malaria (N = 413) | |||
Relative risk | 95% CI | Relative risk | 95% CI | |
Age (for 5 years) | 1.25 | (0.70-2.27) | 1.27 | (0.74-2.18) |
CD4 (for 50 cells/mm3) | 0.83 | (0.71-0.99) | 0.82 | (0.71-0.96) |
Type of anti-malarial chemoprophylaxis (cotrimoxazole alone vs mefloquine IPTp +/− cotrimoxazole) | 1.72 | (0.61-4.89) | 2.24 | (0.83-6.07) |
Antiretroviral therapy started before inclusion | 0.39 | (0.12-1.21) | 0.34 | (0.12-0.98) |
Symptomatic malaria during the early pregnancy (before inclusion) | 8.89 | (2.68-29.52) | 7.1 | (2.35-21.49) |
Primiparity | 1.09 | (0.21-5.58) | 0.84 | (0.17-4.16) |
Delivery during the rainy season | 0.55 | (0.20-1.54) | 0.63 | (0.25-1.60) |